Tomasz Huzarski
The Royal Melbourne Hospital(AU)Walter and Eliza Hall Institute of Medical Research(AU)International Hereditary Cancer Center(PL)Read-Gene (Poland)(PL)University of Zielona Góra(PL)Pomeranian Medical University(PL)
Publications by Year
Research Areas
BRCA gene mutations in cancer, Ovarian cancer diagnosis and treatment, Genetic factors in colorectal cancer, DNA Repair Mechanisms, Nutrition, Genetics, and Disease
Most-Cited Works
- → Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial(2017)1,842 cited
- → Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer(2021)1,582 cited
- → Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation(2014)644 cited
- → CHEK2 Is a Multiorgan Cancer Susceptibility Gene(2004)551 cited
- → Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy(2009)505 cited
- → Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial